Scientific Posters
Formulation selection and development for ME-401 during a first-in-human study in healthy volunteers - AAPS 2016
Formulation selection and development for ME-401, an oral, potent and selective inhibitor of phosphatidylinositol 3-kinase P110δ during a first-in-human study in healthy volunteers.